The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
Social Media and Medicine: A Winning Combination
Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, discusses the potential of social media to change the landscape of clinical practice.
The dissemination of medical information online in real time has forever changed the relationship between today's physician and patient. The idea that accurate and meaningful information can only flow in one direction is now extinct.
How can physicians take advantage of social media (SM)-in the form of online forums, microblogs (eg, Twitter), video, blogs, social networks, and podcasts1-as an opportunity to engage with patients and improve their care?
Here to discuss is Dr Farris Timimi, Assistant Professor of Medicine at the Mayo Clinic and Medical Director of the Mayo Clinic Center for Social Media, in Rochester, Minn. Dr Timimi can be found on Twitter at @FarrisTimimi.
Social Media in Medicine
Take home points
• SM is an opportunity for physicians to change community outcomes and improve patient care
• Because the 3 most common online activities include internet search, e-mail, and searching for health care information, physicians are obligated to put reliable health care information in the path of the patient
• SM is a logical extension of clinical practice, research, and education
• Content curation and content creation have “profound value” to patients and caregiver, so it is incumbent upon physicians to develop and review their organizational SM policy guide1
Reference
1. Timimi FK. Medicine, morality and health care. BMC Med. 2012;10:83.
Co-administration of Arexvy and Shingrix Yields Positive Topline Phase 3 Data, GSK Reports
Immune responses for both vaccines were noninferior when given at the same visit compared with separate administration among adults aged 50 years and older.
Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.
Long-Term Safety of Roflumilast in Adults with COPD: Daily Dose
Your daily dose of the clinical news you may have missed.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose
Your daily dose of the clinical news you may have missed.
FDA Updates Felinzanetant Label Warnings After Report of Severe Liver Injury
FDA heightened label warnings about hepatic injury and increased the required frequency of liver function testing after initiation of fezolinetant.
Co-administration of Arexvy and Shingrix Yields Positive Topline Phase 3 Data, GSK Reports
Immune responses for both vaccines were noninferior when given at the same visit compared with separate administration among adults aged 50 years and older.
Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.
Long-Term Safety of Roflumilast in Adults with COPD: Daily Dose
Your daily dose of the clinical news you may have missed.
Navigating Cardiovascular Complications of Obesity: Expert Insights for Primary Care
Listen to our latest podcast episode for details on top CVD risk factors to screen patients with obesity for, medications to help prevent CVD, and more.
Recent Recreational Drug Use Ups Risk of Repeat Serious CV Event: Daily Dose
Your daily dose of the clinical news you may have missed.
FDA Updates Felinzanetant Label Warnings After Report of Severe Liver Injury
FDA heightened label warnings about hepatic injury and increased the required frequency of liver function testing after initiation of fezolinetant.